Acoustic neuromas (more correctly, vestibular schwannomas) must be one of the most talked-about benign tumours in medicine. Clinicians, particularly otolaryngologists, are constantly encouraged not to miss acoustic neuromas, with the threat of claims for negligence if they do.
With modern imaging techniques tumours only 2 mm in diameter can be diagnosedÐtumours that would have been very dif®cult to detect previously. Probably as a result of these advances, the incidence of acoustic neuromas in clinical practice seems to be increasing. In Denmark it is about one per 100 000 of the population per year 1 , but many may still be undetected in life, because the prevalence of previously undiagnosed acoustic neuroma found at necropsy is around 1% 2 .
How should acoustic neuromas be managed? There are three options, of which surgical removal is the most commonly chosen. In some parts of the world a second option is radiosurgery, but this is rarely used in the UK and I will not refer to it again in this paper. The third and increasingly discussed option is`watchful waiting', whereby the patient is followed up inde®nitely with magnetic resonance imaging (MRI) every 12±18 months, and operated on only if the tumour grows.
When deciding between the ®rst and the third options, one must consider the likely outcomes and, in particular, the possible complications. In acoustic neuroma surgery, the complications to be considered are death, neurological damage, imbalance, facial palsy and the inability to work. We should also remember the words of Gordon Smyth 3 :`In otology, much therapeutic advice to patients is based largely either on published reports from``centres of excellence'' or, in the absence of correctly analysed personal data, on the surgeon's recollection of his or her own past results'. When making a decision to operate, are surgeons overly optimistic about the likely outcomes?
To assess the likelihood of complications, I conducted a Medline search using the terms: acoustic neuroma; therapy, mortality, complications, prevention and control, psychology, epidemiology, economics. The search was limited to the past 10 years because of the substantial advances in imaging and surgical techniques. Of the 252 papers identi®ed, those providing usable data on outcomes and complications of surgery or watchful waiting were included.
COMPLICATIONS OF SURGERY

Death
The mortality rates in different centres vary between 0.5% and 7% (Table 1) . While death is commoner in surgery for larger tumours, some deaths occurred even after operations for intracanalicular tumours 5,7 .
Neurological sequelae
Neurological sequelae with long-term disability occur even after surgery in centres of excellence, again more often when the tumour is large (Table 2) .
Imbalance
Imbalance is often overlooked by surgeons. Few papers report its occurrence but it seems common even a year after surgery (Table 3) . 
Facial function
The most widely accepted method for reporting facial nerve function is the House±Brackmann scale 12 . House± Brackmann grade 3 or worse is a facial palsy with major cosmetic implications for the patient. I refer only to papers that report a postoperative follow-up of at least one year, to avoid including temporary facial palsies (Table 4 ). The facial palsy rate varies substantially, even between centres that seem to be reporting surgery on tumours of comparable size.
Return to work
Few papers report the number of people who were able to return to work. Obviously, many patients are not in employment before having their operations, but a substantial proportion of those still working before surgery are unable to work subsequently (Table 5) .
COMPLICATIONS OF SURGERY FOR SMALL TUMOURS
The general view is that, for small tumours, the outcomes of surgery are much better and the complication rate much less than for largeÐhence the encouragement to detect tumours when they are still small. The de®nition of`small' varies, and in this paper I mean less than 2 or 2.5 cm including both intracanalicular and extracanalicular components. The mortality and neurological complication rates seem to be less than 1%Ðfairly low though greater than after most operations in otolaryngology. However, imbalance is not obviously less frequent than the rates in Table 3 . Facial palsies do seem to arise less frequently but do still occur (Table 6 ). The percentage who are unable to return to work is still around 15%.
VARIATION IN OUTCOMES BETWEEN CENTRES
Why should complication rates vary between series? Either the patients are different or the surgery is different. In Table 6 , the largest series 9 is based on the American Acoustic Neuroma Registry and the data are from 44 surgical groups, though 26% of the patients came from only two groups. It it likely that these two groups are among those which publish their results and their results may be as good as the better ones previously quotedÐthe``centres of excellence''. In that case, some of the others' results are signi®cantly worse than average. Buchman reported the learning curve of himself and his colleagues 20 in their ®rst 96 patients, dividing them into ®ve patient bands in which tumour size did not differ. They had to operate on 60 cases before their facial nerve results were similar to those of the experts (Table 7) .
QUALITY OF LIFE AFTER SURGERY
Quality of life is rarely reported after surgery for acoustic neuroma. Nikolopoulos 21 looked at quality of life in 53 patients who were 1±3 years post-surgery, using the Glasgow Bene®t Inventory 22 . 17% of patients claimed that their quality of life was better after surgery, 29% said it was the same but 54% said it was worse. The results were not related to tumour size.
J O U R N A L O F T H E R O Y A L S O C I E T Y O F M E D I C I N E
V o l u m e 9 3 D e c e m b e r 2 0 0 0 Irving 23 looked at 227 patients from 6 months to 8 years after surgery using a standardized quality of life questionnaire designed for cancer patients (EORTC QLQ±C30). He concluded that`in general, the quality of life was excellent'. However, a poor outcome was de®ned as a score less than 50%. This occurred in 14% who had tumours less than 2.5 cm in diameter and 15% with larger tumoursÐfurther evidence that the size of the tumour operated on makes little difference.
WATCHFUL WAITING
The aim of watchful waiting is to use imaging, usually MRI, every 12±18 months and see if the tumour is growing, growth normally being taken as an indication for surgery. Many papers report the results of watchful waiting, mostly in small series of patients. Even in the large series the rates of tumour growth vary greatly (Table 8 ). Most authors do not de®ne tumour growth but merely say that increase in tumour size was observed on imaging. From all papers it is clear that some tumours do not grow even in many years. The follow-up has been as long as 8 years 25 or 12 years 28 .
There are some advantages to watchful waiting: the tumour might not grow; if it does, surgery can then be carried out (the increase in risk seems negligible); quality of life during the period of watchful waiting will be unchanged. Jorgensen 8 certainly supports the idea and remarks,`20 neuromas (of 78) have not been operated upon and this group of patients is a group which has managed by far the best'.
Sometimes the reason given for not considering watchful waiting is the possibility that hearing can be preserved in the ear with the neuroma. Reviewing recent work on this subject, Welling 30 found that the ®gures varied considerably according to methods of selecting patients. Using the AAOHNS criteria 31 of pure tone average better than 30 dB and speech discrimination better than 70%, he concluded that only 20±25% of patients were suitable for an attempt at hearing preservation and in only 25±30% of these patients was this achieved. The possibility of hearing preservation therefore applies only to a very small proportion of patients.
CONCLUSIONS
The experts are the people who usually tell us about their results, and these are the results that we remember and tend to in¯uence our clinical decisions. Unfortunately, the outcomes of acoustic neuroma surgery, even for small tumours (Table 9) , are often not as good as the expert surgeons achieve. This is true of many other branches of surgery.
Sometimes we should put ourselves in the position of the patient. If you had a small acoustic neuroma, about 1.5 cm perhaps, what would you do? It might not grow, so watchful waiting would be an option to consider. While waiting, you could look for a surgeon who audited his or her own results and whose results were proven to be acceptable. 
